News

Jan 2023   Kamsiyochukwu is from Nigeria and he suffered from the hereditary blood disorder Sickle Cell Anaemia. He needed a stem cell transplant to cure his disease, but he did not have a match in the public registries of donors. He was saved by a cord blood transplant from his baby brother. His mother gives thanks to the cord blood bank that made this transplant possible. The bank also paid towards their medical costs through an insurance program.

Dec 2022   Eric traveled to Thailand for MSC therapy to help him recover from a traumatic brain injury. He had previously undergone months of testing and conventional therapy in the United States, but felt that his recovery was not complete. At the hospital in Thailand, the MSC were injected both into his spine and into his bloodstream. The MSC came from a laboratory that had AABB somatic cell accreditation. Eric feels that his recovery is now complete and he can once again devote himself to the charity he founded.

Dec 2022   The answer is NO. Due to growing awareness of the value of donated placentas, parents frequently ask questions about selling their placenta. The purpose of this article is to explain why you can’t sell a placenta.

Nov 2022   Little Gauri is the second child saved by a cord blood transplant from the LifeCell Community Bank. Like thousands of children in India, Gauri suffers from Thalassemia Major, but did not have a matching stem cell donor in her family. With the birth of her baby sibling, Gauri's parents signed up to bank cord blood in the LifeCell Community Bank. Thanks to the inventory shared by members of the community, Gauri received a matching cord blood transplant from an unrelated donor.

Nov 2022   Michal is a mother of three children on the autism spectrum. She has created a website that gives parents a how to guide for seeking cell therapy for autism.

Oct 2022   FamiCord Group is a network of family banking companies and 15 laboratories that together hold 50% of the cord blood banking market in Europe. In this interview we learn how FamiCord built this dominance and what trends they see for the future of biobanking and cell therapy in Europe.

Oct 2022   This story tells the experiences of a family from Japan whose son has HIE from a birth injury. They banked his younger sister's umbilical cord blood at the StemCell Institute. Thanks to the banked sibling cord blood, the family was able to travel to Duke for their son to receive cell therapy through the Duke Expanded Access program (EAP).

Sep 2022   The Cryoviva Group has cord blood laboratories in Thailand, Singapore, India, and Vietnam, and is active in banking MSC for regenerative medicine therapies. The Cryoviva Group believes that the future of the biobanking industry is to partner in providing cell therapies.

Sep 2022   ExCellThera is a biotechnology company based in Montréal that is dedicated to making cord blood transplants available to a more diverse group of patients by expanding small cord blood units so that they are big enough for therapy.

Aug 2022   Currently, 110 clinical trials with cord blood are recruiting at 281 locations. Cumulatively, 276 clinical trials performing advanced cell therapies with cord blood have been registered through the end of 2021.